Joseph Bratica
Comptroller/Controller/Auditor bei SAREPTA THERAPEUTICS, INC.
Profil
Joseph Bratica ist Vice President & Controller bei Sarepta Therapeutics, Inc. Zuvor hatte er die Position des Accounting Manager bei Creative Biomolecules, Inc. und Vice President-Finance & Controller bei ARIAD Pharmaceuticals, Inc. inne. Er erhielt einen Bachelor-Abschluss von der Suffolk University.
Aktive Positionen von Joseph Bratica
| Unternehmen | Position | Beginn |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.03.2017 |
Ehemalige bekannte Positionen von Joseph Bratica
| Unternehmen | Position | Ende |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.01.2016 |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Comptroller/Controller/Auditor | 01.01.1994 |
Ausbildung von Joseph Bratica
| Suffolk University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Creative Biomolecules, Inc.
Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
